Research Article

Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata

Volume: 8 Number: 5 September 11, 2026

Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata

Abstract

Aims: Esophageal variceal bleeding (EVB) remains a major cause of morbidity and mortality in patients with liver cirrhosis. Although endoscopic grading is central to risk stratification, it remains uncertain whether non-invasive fibrosis-based indices provide additional discriminatory value among patients with advanced (F3) esophageal varices without high-risk endoscopic stigmata. Methods: This retrospective single-center cohort study included 69 cirrhotic patients with F3 esophageal varices without red wale marks at index endoscopy. Baseline Child-Pugh, Model for endstage liver disease (MELD), Aminotransferase-to-Platelet Ratio Index (APRI), and fibrosis-4 (FIB-4) scores were calculated using laboratory measurements obtained within one week of the index endoscopy. The primary outcome was the mode of clinical presentation during follow-up, defined as acute variceal bleeding requiring emergency endoscopy or elective endoscopic band ligation following the development of newly detected red wale marks during scheduled surveillance. Receiver operating characteristic (ROC) analysis and logistic regression were performed to evaluate the association and discriminatory performance of baseline non-invasive markers. Results: During follow-up, 49 patients presented with acute variceal bleeding and 20 underwent elective endoscopic band ligation after developing newly detected red wale marks. Baseline FIB-4 scores were significantly higher in the bleeding presentation group than in the elective intervention group (4.9 vs. 2.9, p<0.001). FIB-4 demonstrated good discriminatory ability [area under the curve=0.816; 95% confidence interval (CI), 0.710-0.910] and remained independently associated with bleeding presentation in multivariable logistic regression analysis (odds ratio 1.86, 95% CI 1.24-2.79; p=0.003). APRI and MELD showed lower discriminatory performance and were not independently associated with the study outcome. Conclusion: Among cirrhotic patients with F3 esophageal varices without high-risk endoscopic stigmata, higher baseline FIB-4 scores were independently associated with bleeding presentation during follow-up. These findings suggest that FIB-4 may provide complementary biological information beyond conventional endoscopic assessment and may contribute to individualized risk stratification following prospective validation.

Keywords

References

  1. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII-renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974. doi:10.1016/j.jhep.2021.12.022
  2. Gralnek IM, Camus Duboc M, Garcia-Pagan JC, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2022;54(11):1094-1120. doi:10.1055/a-1939-4887
  3. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48 Suppl 1:S68-S92. doi:10.1016/j.jhep.2008.01.021
  4. Kaplan DE, Ripoll C, Thiele M, et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2024;79(5):1180-1211. doi:10.1097/HEP.0000000000000647
  5. Ishida K, Namisaki T, Murata K, et al. Accuracy of Fibrosis-4 Index in identification of patients with cirrhosis who could potentially avoid variceal screening endoscopy. J Clin Med. 2020;9(11):3510. doi:10.3390/jcm9113510
  6. Thandassery RB, John N, Mashal FA, et al. Predicting esophageal varices and varices needing treatment in compensated advanced chronic liver disease. Dig Dis Sci. 2025;70(11):3679-3685. doi:10.1007/s10620-025-09193-7
  7. Cifci S, Ekmen N. Evaluation of non-invasive fibrosis markers in predicting esophageal variceal bleeding. Clin Endosc. 2021;54(6):857-863. doi:10.5946/ce.2021.028
  8. Tian Q, Liu Y, Cao Q, et al. Clinical value of APRI and FIB-4 on bleeding risk and 30-day prognosis in patients with liver cirrhosis complicated with esophagogastric varices. Int J Gen Med. 2025;18:6153-6167. doi:10.2147/IJGM.S545850

Details

Primary Language

English

Subjects

Gastroenterology and Hepatology

Journal Section

Research Article

Publication Date

September 11, 2026

Submission Date

June 2, 2026

Acceptance Date

July 29, 2026

Published in Issue

Year 2026 Volume: 8 Number: 5

APA
Küçükdemirci, Ö., & Baş, B. (2026). Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata. Anatolian Current Medical Journal, 8(5), 960-967. https://doi.org/10.38053/acmj.1962302
AMA
1.Küçükdemirci Ö, Baş B. Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata. Anatolian Curr Med J / ACMJ / acmj. 2026;8(5):960-967. doi:10.38053/acmj.1962302
Chicago
Küçükdemirci, Ömer, and Berk Baş. 2026. “Association Between Baseline FIB-4 Score and Bleeding Presentation Among Cirrhotic Patients With F3 Esophageal Varices Without High-Risk Stigmata”. Anatolian Current Medical Journal 8 (5): 960-67. https://doi.org/10.38053/acmj.1962302.
EndNote
Küçükdemirci Ö, Baş B (September 1, 2026) Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata. Anatolian Current Medical Journal 8 5 960–967.
IEEE
[1]Ö. Küçükdemirci and B. Baş, “Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata”, Anatolian Curr Med J / ACMJ / acmj, vol. 8, no. 5, pp. 960–967, Sept. 2026, doi: 10.38053/acmj.1962302.
ISNAD
Küçükdemirci, Ömer - Baş, Berk. “Association Between Baseline FIB-4 Score and Bleeding Presentation Among Cirrhotic Patients With F3 Esophageal Varices Without High-Risk Stigmata”. Anatolian Current Medical Journal 8/5 (September 1, 2026): 960-967. https://doi.org/10.38053/acmj.1962302.
JAMA
1.Küçükdemirci Ö, Baş B. Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata. Anatolian Curr Med J / ACMJ / acmj. 2026;8:960–967.
MLA
Küçükdemirci, Ömer, and Berk Baş. “Association Between Baseline FIB-4 Score and Bleeding Presentation Among Cirrhotic Patients With F3 Esophageal Varices Without High-Risk Stigmata”. Anatolian Current Medical Journal, vol. 8, no. 5, Sept. 2026, pp. 960-7, doi:10.38053/acmj.1962302.
Vancouver
1.Ömer Küçükdemirci, Berk Baş. Association between baseline FIB-4 score and bleeding presentation among cirrhotic patients with F3 esophageal varices without high-risk stigmata. Anatolian Curr Med J / ACMJ / acmj. 2026 Sep. 1;8(5):960-7. doi:10.38053/acmj.1962302

 

TR DİZİN ULAKBİM and International Indexes (1b)
 

Interuniversity Board (UAK) Equivalency:  Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show

 

Journal Indexes and Platforms: 

TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.


 

The indexes of the journal's are;


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiMDFiOS82MmZhLzA3MzMvNjlkZjNlNTdhMmI4ZjkuODYxMzMxMjQucG5nIiwiZXhwIjoxNzc2MjQxNzY3LCJub25jZSI6ImQyMTQ4MjdiNTg1ZjVmMGQwYzAzZTMxNzMwM2QwMThmIn0.RmnGvwR536HdIoKpGO-ApytZ5aRPRT_BFXE2EpGSIqc


 
f9ab67f.png
 
WorldCat_Logo_H_Color.png
 

 

18596download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiT3BlbkFpcmUuanBnIiwicGF0aCI6IjUyMWYvZjljYy8wMDk3LzY5ZGYzZDNiYmVkZGU0LjQzNDM2OTU3LmpwZyIsImV4cCI6MTc3NjI0MTQ4NCwibm9uY2UiOiIwYjgxZDE2NzRiNzhjMWQyOGVmMDM1OTA1MzI5NjdjZiJ9.xeFppR1ubA4i-dHG-u07ht9bQNogFheXQjLyEaP9GgAdownload?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiYXNvcy1pbmRleC5wbmciLCJwYXRoIjoiYmIxYy80MmRmL2I3NjcvNmFiY2Y5ZTBhN2NiNTUuMDA0MTgyMDYucG5nIiwiZXhwIjoxNzkwNzczMjMzLCJub25jZSI6ImI2NTk3NDU5YWJjN2Q5ZWVlNjc1YmFkOTUwZjVjOTA1In0.IOi1HkOQa2DrBFgKt2AaWnPQgFJ0TlpInBgU4WLd-AU

 

84039476_619085835534619_7808805634291269632_n.jpg

 

 

 

The platforms of the journal's are;
 

COPE.jpg
 
images?q=tbn:ANd9GcTbq2FM8NTdXECzlOUCeKQ1dvrISFL-LhxhC7zy1ZQeJk-GGKSx2XkWQvrsHxcfhtfHWxM&usqp=CAUicmje_1_orig.png
 
 
download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiTkNCSS5wbmciLCJwYXRoIjoiNGZkZC9iZDEyLzZjNzQvNmFiY2Y5NzdlNzU4OTYuMzYxNjc5OTEucG5nIiwiZXhwIjoxNzkwNzczMTI4LCJub25jZSI6IjFkOGY1MmE5NDM2NjZlN2E5MGM5MzUzMDU5ZTQ1ZDNiIn0.QoqgQoaHV57TPHNK7wnDrODQ-NbON6P78-EXqz7know
 
images?q=tbn:ANd9GcQlwX77nfpy3Bu9mpMBZa0miWT2sRt2zjAPJKg2V69ODTrjZM1nT1BbhWzTVPsTNKJMZzQ&usqp=CAU
 

 

images?q=tbn:ANd9GcTaWSousoprPWGwE-qxwxGH2y0ByZ_zdLMN-Oq93MsZpBVFOTfxi9uXV7tdr39qvyE-U0I&usqp=CAU
 


 


 

 


 


The indexes/platforms of the journal are;
 

TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit 
 


Journal articles are evaluated as "Double-Blind Peer Review"

 

All articles published in this journal are licensed under a Creative Commons Attribution 4.0 International License (CC BY NC ND)